178 related articles for article (PubMed ID: 23271221)
21. Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis.
Passamonti L; Cerasa A; Liguori M; Gioia MC; Valentino P; Nisticò R; Quattrone A; Fera F
Brain; 2009 Dec; 132(Pt 12):3380-91. PubMed ID: 19420090
[TBL] [Abstract][Full Text] [Related]
22. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
23. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.
Deloire MS; Salort E; Bonnet M; Arimone Y; Boudineau M; Amieva H; Barroso B; Ouallet JC; Pachai C; Galliaud E; Petry KG; Dousset V; Fabrigoule C; Brochet B
J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):519-26. PubMed ID: 15774439
[TBL] [Abstract][Full Text] [Related]
24. Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Panou T; Mastorodemos V; Papadaki E; Simos PG; Plaitakis A
Behav Neurol; 2012; 25(4):311-26. PubMed ID: 22713377
[TBL] [Abstract][Full Text] [Related]
25. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
[TBL] [Abstract][Full Text] [Related]
26. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
[TBL] [Abstract][Full Text] [Related]
27. Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
Cogo MG; Rota S; Fusco ML; Mapelli C; Ferri F; Appollonio IM; Isella V
J Clin Exp Neuropsychol; 2014; 36(10):1066-75. PubMed ID: 25486588
[TBL] [Abstract][Full Text] [Related]
28. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
[TBL] [Abstract][Full Text] [Related]
29. Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study.
Zaaraoui W; Konstandin S; Audoin B; Nagel AM; Rico A; Malikova I; Soulier E; Viout P; Confort-Gouny S; Cozzone PJ; Pelletier J; Schad LR; Ranjeva JP
Radiology; 2012 Sep; 264(3):859-67. PubMed ID: 22807483
[TBL] [Abstract][Full Text] [Related]
30. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
Nygaard GO; Walhovd KB; Sowa P; Chepkoech JL; Bjørnerud A; Due-Tønnessen P; Landrø NI; Damangir S; Spulber G; Storsve AB; Beyer MK; Fjell AM; Celius EG; Harbo HF
Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
[TBL] [Abstract][Full Text] [Related]
31. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; De Masi R; Nasuelli D; Bragadin LM; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
Neuroradiology; 2001 Apr; 43(4):272-8. PubMed ID: 11338408
[TBL] [Abstract][Full Text] [Related]
32. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
[TBL] [Abstract][Full Text] [Related]
33. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
[TBL] [Abstract][Full Text] [Related]
34. Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment.
Moroso A; Ruet A; Lamargue-Hamel D; Munsch F; Deloire M; Coupé P; Charré-Morin J; Saubusse A; Ouallet JC; Planche V; Tourdias T; Dousset V; Brochet B
PLoS One; 2017; 12(8):e0182479. PubMed ID: 28792528
[TBL] [Abstract][Full Text] [Related]
35. Differential cerebellar functional interactions during an interference task across multiple sclerosis phenotypes.
Rocca MA; Bonnet MC; Meani A; Valsasina P; Colombo B; Comi G; Filippi M
Radiology; 2012 Dec; 265(3):864-73. PubMed ID: 22966067
[TBL] [Abstract][Full Text] [Related]
36. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.
Kincses ZT; Ropele S; Jenkinson M; Khalil M; Petrovic K; Loitfelder M; Langkammer C; Aspeck E; Wallner-Blazek M; Fuchs S; Jehna M; Schmidt R; Vécsei L; Fazekas F; Enzinger C
Mult Scler; 2011 Jun; 17(6):681-9. PubMed ID: 21177325
[TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype.
Riccitelli G; Rocca MA; Pagani E; Rodegher ME; Rossi P; Falini A; Comi G; Filippi M
Hum Brain Mapp; 2011 Oct; 32(10):1535-43. PubMed ID: 20740643
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).
Comi G; Patti F; Rocca MA; Mattioli FC; Amato MP; Gallo P; Centonze D; Pozzilli C; Saccà F; Bergh FT; Bartezaghi M; Turrini R; Filippi M;
J Neurol; 2017 Dec; 264(12):2436-2449. PubMed ID: 29063244
[TBL] [Abstract][Full Text] [Related]
39. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
[TBL] [Abstract][Full Text] [Related]
40. Structural correlates for fatigue in early relapsing remitting multiple sclerosis.
Wilting J; Rolfsnes HO; Zimmermann H; Behrens M; Fleischer V; Zipp F; Gröger A
Eur Radiol; 2016 Feb; 26(2):515-23. PubMed ID: 26026721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
